The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based… read more
-
ETF
Equity
- years
11 holdings
$5.60
Price-3.78%
-$0.22
$60.616m
Small
$15.299m
Avg Volume$96.536m
$5.47
NAV1.10%
Expense Ratio2.68%
Yield$0.15
Dividend